Li Long
Corporate Officer/Principal bij KEZAR LIFE SCIENCES, INC.
Profiel
Li Long is currently working as Vice President-Immunology Clinical Development at Kezar Life Sciences, Inc. Prior to this, Dr. Long worked as Senior Director-Clinical Development at Principia Biopharma, Inc. Dr. Long holds a doctorate degree from McGill University.
Actieve functies van Li Long
| Bedrijven | Functie | Begin |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Corporate Officer/Principal | - |
Eerdere bekende functies van Li Long
| Bedrijven | Functie | Einde |
|---|---|---|
| PRINCIPIA BIOPHARMA INC. | Corporate Officer/Principal | - |
Opleiding van Li Long
| McGill University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KEZAR LIFE SCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |